Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes.
The Numbers
Selected comments from the leaders of top orthopedic companies as they reported first quarter 2026 earnings.
Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.
Orthoflash®
Smith+Nephew’s CORI XT is designed to be the single handheld robotics platform for all orthopedic needs, including partial to revision knee, hip, and anatomic and reverse shoulders.
June 9, 2026
,
NanoCept-coated implants are designed to support oncology and revision patients, populations that may face elevated risk for bacterial contamination.
June 9, 2026
,
Real-world outcomes data confirm the safety and efficacy of ultrasound-guided carpal tunnel release to treat CTS in routine clinical practice, including simultaneous bilateral procedures.
June 9, 2026
,
TRAQTION, a prospective, multicenter clinical study, will evaluate outcomes associated with posterior SI joint procedures using the cortical-piercing TRAQ allograft.
June 9, 2026
,
The expandable design incorporates NanoACTIV Surface and NeoWave Structure Technologies to enhance the potential for fusion.
June 8, 2026
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
